The use of mifepristone in the treatment of neuropsychiatric disorders

被引：77
作者：
DeBattista, C [1 ]
Belanoff, J [1 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
TRENDS IN ENDOCRINOLOGY AND METABOLISM | 2006年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.tem.2006.02.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Mifepristone is a potent glucocorticoid and progesterone receptor antagonist. The pathophysiology of a number of neuropsychiatric disorders implicates abnormalities in glucocorticoid function. These include mood disorders such as psychotic major depression and bipolar depression. In addition, cognitive disorders such as Alzheimer's disease might also be partially mediated by abnormalities in the hypothalamic-pituitary-adrenal axis. Preliminary studies suggest that mifepristone might have a role in the treatment of a number of neuropsychiatric disorders.
引用
收藏
页码：117 / 121
页数：5
相关论文
共 44 条
  • [1] An open label trial of C-1073 (mifepristone) for psychotic major depression
    Belanoff, JK
    Rothschild, AJ
    Cassidy, F
    DeBattista, C
    Baulieu, EE
    Schold, C
    Schatzberg, AF
    [J]. BIOLOGICAL PSYCHIATRY, 2002, 52 (05) : 386 - 392
  • [2] Rapid reversal of psychotic depression using mifepristone
    Belanoff, JK
    Flores, BH
    Kalezhan, M
    Sund, B
    Schatzberg, AF
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (05) : 516 - 521
  • [3] MIFEPRISTONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL
    BROGDEN, RN
    GOA, KL
    FAULDS, D
    [J]. DRUGS, 1993, 45 (03) : 384 - 409
  • [4] Cadepond F, 1997, ANNU REV MED, V48, P129
  • [5] Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486)
    Chu, JW
    Matthias, DF
    Belanoff, J
    Schatzberg, A
    Hoffman, AR
    Feldman, D
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) : 3568 - 3573
  • [6] DEBATTISTA C, 2003, AM COLL NEUR ANN M S
  • [7] DEBATTISTA C, 2004, 44 ANN NCDEU M PHOEN
  • [8] DeBattista Charles, 2005, Current Alzheimer Research, V2, P125
  • [9] Cortisol level predicts executive and memory function in depression, symptom level predicts psychomotor speed
    Egeland, J
    Lund, A
    Landro, NI
    Rund, BR
    Sundet, K
    Asbjornsen, A
    Mjellem, N
    Roness, A
    Stordal, KI
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2005, 112 (06) : 434 - 441
  • [10] Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas
    Eisinger, SH
    Bonfiglio, T
    Fiscella, K
    Meldrum, S
    Guzick, DS
    [J]. JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2005, 12 (03) : 227 - 233
12345